Researchers have identified a pathway at work within the nuclei of astrocyte cells involved in the regulation of TGF-beta signaling, which may be involved in various brain diseases.
Former NFL players who participated in tackle football before the age of 12 may have a higher risk of altered brain development when compared to those who started at a later age.
Premature birth and low birth weight have been linked to an increased risk of schizophrenia in individuals with 22q11.2 deletion syndrome.
A recent investigation suggests that a drug commonly used to treat liver disease – ursodeoxycholic acid – could slow the progression of Parkinson’s disease.
New study suggests targeting brain cancer treatment to cells surrounding a tumor in order to prevent spread.
Inhibikase Therapeutics’ new study will investigate JC virus viral load and antibody titer in progressive multifocal leukoencephalopathy survivors.
A social skills program for high-functioning young adults with autism spectrum disorder has been shown to considerably improve the participants’ ability to engage with others.
A novel gene-expression study focusing on neurotransmitter regulation in depression offers possible explanation for gender disparities in suicide rates and reveals potential new targets for antidepressant drugs.
A new large-scale animal study designed with the aim of mimicking the rigor of a human clinical trial has highlighted the potential of preclinical randomized controlled trials in evaluating a drug’s efficacy, potentially bridging the gap between successful laboratory experiments and failed clinical trials.